BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17477780)

  • 1. Cancer screening with whole-body PET/CT for healthy asymptomatic people in Japan: re-evaluation of its test validity and radiation exposure.
    Ghotbi N; Iwanaga M; Ohtsuru A; Ogawa Y; Yamashita S
    Asian Pac J Cancer Prev; 2007; 8(1):93-7. PubMed ID: 17477780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey.
    Murano T; Minamimoto R; Senda M; Uno K; Jinnouchi S; Fukuda H; Iinuma T; Tsukamoto E; Terauchi T; Yoshida T; Oku S; Nishizawa S; Ito K; Oguchi K; Kawamoto M; Nakashima R; Iwata H; Inoue T
    Ann Nucl Med; 2011 Nov; 25(9):657-66. PubMed ID: 21720777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
    Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
    Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.
    Nishizawa S; Kojima S; Teramukai S; Inubushi M; Kodama H; Maeda Y; Okada H; Zhou B; Nagai Y; Fukushima M
    J Clin Oncol; 2009 Apr; 27(11):1767-73. PubMed ID: 19255324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
    Willowson KP; Bailey EA; Bailey DL
    Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening of asymptomatic individuals using 18F-FDG PET/CT in China: a retrospective study.
    Tong J; Zou Y; Jiang J; Shi W; Tao R; Ye J; Lu Y; Jiang X; Wang W
    Discov Med; 2016 Oct; 22(121):181-188. PubMed ID: 27875669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening with FDG-PET.
    Ide M
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):23-7. PubMed ID: 16557201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Terauchi T; Jinnouchi S; Inoue T; Iinuma T; Inoue T; Ito K; Iwata H; Uno K; Oku S; Oguchi K; Tsukamoto E; Nakashima R; Nishizawa S; Fukuda H; Murano T; Yoshida T
    Ann Nucl Med; 2011 Jan; 25(1):45-54. PubMed ID: 20953985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Anticancer Res; 2014 Aug; 34(8):4439-45. PubMed ID: 25075083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Performance profile of FDG-PET and PET/CT for cancer screening based on a Japanese nationwide survey].
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Kaku Igaku; 2007 May; 44(2):105-24. PubMed ID: 18240583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
    Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
    BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of PET and PEt/CT imaging for cancer screening.
    Chen YK; Ding HJ; Su CT; Shen YY; Chen LK; Liao AC; Hung TZ; Hu FL; Kao CH
    Anticancer Res; 2004; 24(6):4103-8. PubMed ID: 15736459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.
    Wen JC; Sai V; Straatsma BR; McCannel TA
    JAMA Ophthalmol; 2013 Jan; 131(1):56-61. PubMed ID: 23307209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mondal A; Mishra AK; Dwarakanath BS
    Indian J Med Res; 2015 Dec; 142(6):721-31. PubMed ID: 26831421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.